# Feature Specification: Drug Interaction Compositional Checker

## Overview

**Product**: Categorical Drug Interaction Safety System
**Version**: 1.0
**Status**: Draft
**Last Updated**: 2024-11-29

### Summary

Build a drug interaction checking system that models drug combinations as a monoidal category, where the tensor product represents combining drugs and safety scores degrade through composition. The system uses enriched categories to track cumulative safety and identifies high-risk combinations.

### Problem Statement

Drug combinations have complex interactions that create combinatorial explosion of possibilities. Healthcare providers need:
- Systematic checking of multi-drug regimens
- Compositional safety scoring that accounts for compounding risk
- Clear identification of contraindicated combinations
- Alternative suggestions when dangerous interactions detected

---

## User Scenarios

### US1: Basic Interaction Check [P1]

**As a** pharmacist
**I want to** check a list of medications for interactions
**So that** I can identify potential safety risks

**Given** a list of drug names (e.g., warfarin, aspirin, metformin)
**When** I run the interaction checker
**Then** I see all pairwise interactions with severity levels
**And** I see a composite safety score for the full combination
**And** high-risk interactions are prominently flagged

**Acceptance Criteria**:
- [ ] Supports 2-15 drugs per check
- [ ] Identifies interactions from database (DrugBank/FDA)
- [ ] Severity levels: Contraindicated, Major, Moderate, Minor, None
- [ ] Composite score in [0,1] where lower = more dangerous

### US2: Compositional Safety Analysis [P1]

**As a** clinical pharmacologist
**I want to** see how safety degrades through drug combinations
**So that** I understand the compounding risk

**Given** multiple drugs with pairwise interactions
**When** the system computes composite safety
**Then** I see the tensor product chain showing safety degradation
**And** I understand which drug pairs contribute most to risk
**And** the mathematical composition is transparent

**Acceptance Criteria**:
- [ ] Show individual pairwise safety scores
- [ ] Display step-by-step composition (A ⊗ B → C)
- [ ] Identify the "weakest link" interaction
- [ ] Composite safety = product of individual safeties

### US3: Alternative Regimen Suggestion [P2]

**As a** prescribing physician
**I want to** see safer alternative drug combinations
**So that** I can modify the treatment plan

**Given** a high-risk drug combination
**When** I request alternatives
**Then** the system suggests safer substitutions
**And** shows the safety improvement for each alternative
**And** preserves therapeutic intent where possible

**Acceptance Criteria**:
- [ ] Identify problematic drug(s) in the combination
- [ ] Suggest alternatives from same therapeutic class
- [ ] Show before/after safety comparison
- [ ] Flag when no safe alternative exists

### US4: Regimen Comparison [P2]

**As a** clinical researcher
**I want to** compare safety profiles of different regimens
**So that** I can recommend optimal treatment protocols

**Given** two or more drug regimens
**When** I run comparative analysis
**Then** I see side-by-side safety metrics
**And** the safer regimen is highlighted
**And** specific interaction differences are shown

**Acceptance Criteria**:
- [ ] Compare 2-5 regimens simultaneously
- [ ] Show composite safety for each
- [ ] Identify interactions unique to each regimen
- [ ] Provide clear recommendation with rationale

### US5: Batch Patient Analysis [P3]

**As a** hospital pharmacist
**I want to** check multiple patient regimens at once
**So that** I can efficiently review medication safety

**Given** a batch of patient medication lists
**When** I run batch analysis
**Then** I see risk-ranked list of patients
**And** high-risk patients are flagged for review
**And** summary statistics are provided

**Acceptance Criteria**:
- [ ] Process 10-100 patient regimens
- [ ] Rank by composite safety (ascending = most dangerous)
- [ ] Generate summary report
- [ ] Export results to CSV/JSON

---

## Functional Requirements

### FR-001: Interaction Database
The system SHALL maintain a database of drug interactions including:
- Drug pairs with known interactions
- Severity classification (0.0-1.0 safety score)
- Mechanism of interaction
- Clinical effect/recommendation

### FR-002: Monoidal Category Structure
The system SHALL model drug combinations as:
- Objects: Individual drugs
- Tensor product: Drug combination
- Identity: Empty prescription (safety = 1.0)
- Composition: Sequential/simultaneous administration

### FR-003: Safety Score Computation
The system SHALL compute safety using [0,1]-enriched category:
- Each interaction has safety score in [0,1]
- Composition uses multiplication (tensor product)
- Final safety = product of all pairwise safeties

### FR-004: Severity Classification
The system SHALL classify combinations as:
- Contraindicated: safety < 0.2
- Major: 0.2 ≤ safety < 0.4
- Moderate: 0.4 ≤ safety < 0.7
- Minor: 0.7 ≤ safety < 0.9
- None: safety ≥ 0.9

### FR-005: Alternative Finding
The system SHALL suggest alternatives by:
- Identifying drugs in same therapeutic class
- Computing safety of alternative regimen
- Ranking alternatives by safety improvement

---

## Non-Functional Requirements

### NFR-001: Performance
- Interaction lookup: < 10ms per pair
- Full regimen check (10 drugs): < 500ms
- Batch processing: < 10 seconds for 100 patients

### NFR-002: Accuracy
- Interaction database from authoritative sources (DrugBank, FDA)
- Regular updates to reflect new findings
- No false negatives for contraindicated pairs

### NFR-003: Safety
- Never miss contraindicated combinations
- Conservative scoring (prefer false positives)
- Clear disclaimers about clinical judgment

---

## Success Criteria

| Metric | Target | Measurement |
|--------|--------|-------------|
| Interaction Detection | 100% | No missed contraindicated pairs |
| Processing Speed | < 1s | Average time for 10-drug regimen |
| Alternative Accuracy | > 80% | Alternatives are therapeutically appropriate |
| User Trust | > 4/5 | Clinician confidence survey |

---

## Categorical Structures

### Monoidal Category: Drug Combinations

```
Objects: Drugs
Tensor (⊗): Drug combination
Unit (I): Empty prescription

Axioms:
- Associativity: (A ⊗ B) ⊗ C ≅ A ⊗ (B ⊗ C)
- Unit: I ⊗ A ≅ A ≅ A ⊗ I
- Symmetry: A ⊗ B ≅ B ⊗ A (order doesn't matter for safety)
```

### Enriched Category: Safety Tracking

```
Hom(A, B) ∈ [0,1]  -- Safety of combining A with B
Composition: Hom(A,B) ⊗ Hom(B,C) → Hom(A,C)
           : safety(A,B) × safety(B,C) = cumulative

Identity: Hom(A,A) = 1.0 (drug with itself is safe)
```

### Safety Degradation Diagram

```
Warfarin ──(0.7)──▶ +Omeprazole ──(0.2)──▶ +Aspirin
     │                    │                    │
     └────────────────────┴────────────────────┘
                         │
                         ▼
            Composite: 0.7 × 0.2 = 0.14
            Classification: CONTRAINDICATED
```

---

## Data Sources

### Primary: DrugBank (Open Data)
- 13,000+ drug entries
- Drug-drug interactions with severity
- Mechanism descriptions
- Free for non-commercial use

### Secondary: FDA Drug Interactions
- Official FDA warnings
- Black box warnings
- Updated regularly

### Tertiary: SIDER
- Side effect database
- Phenotypic drug-drug interactions

---

## Open Questions

1. **NEEDS CLARIFICATION**: Should we include supplement and food interactions?
2. **NEEDS CLARIFICATION**: How to handle dose-dependent interactions?
3. **NEEDS CLARIFICATION**: What therapeutic class ontology to use for alternatives?

---

## References

- DrugBank Database (https://go.drugbank.com/)
- FDA Drug Interaction Guidelines
- Monoidal Categories (Mac Lane, "Categories for the Working Mathematician")
- Enriched Category Theory (Kelly, "Basic Concepts of Enriched Category Theory")
